The study included 13 subjects with glaucomatous visual field loss and 13 controls. Participants from this study were drawn from a prospective longitudinal study designed to evaluate functional impairment in glaucoma. The institutional review board approved all the methods, and written informed consent was obtained from all participants. The study adhered to the laws of the Health Insurance Portability and Accountability Act, and all study methods complied with the Declaration of Helsinki guidelines for human subject research.
All participants underwent a comprehensive ophthalmologic examination including review of medical history, visual acuity, slit-lamp biomicroscopy, IOP measurement using Goldmann applanation tonometry, corneal pachymetry, gonioscopy, dilated fundoscopy examination using a 78-diopter lens, stereoscopic optic disc photography, SAP using the 24-2 Swedish Interactive Threshold Algorithm (SITA) Standard of the Humphrey Field Analyzer II, model 750 (Carl Zeiss Meditec, Inc., Dublin, CA, USA), and OCT. Only subjects with open angles on gonioscopy were included. Patients with coexisting retinal disease, uveitis, or nonglaucomatous optic disc neuropathy were excluded from the study.
Glaucoma was defined as the presence of two or more consecutive abnormal SAP tests at baseline, characterized by a pattern standard deviation (PSD) with P < 0.05 and/or glaucoma hemifield test results outside normal limits, and evidence of glaucomatous optic neuropathy based on masked assessment of stereo photographs. Healthy control subjects were recruited from the general population and had IOP of 21 mm Hg or less, SAP results within normality, and were required to have normal appearance of the optic disc on masked grading of stereo photographs.